June 17, 2020

OPTIMA Supporting Catalent with New High-Speed Vial Filling Line for COVID-19 Vaccine Program

Filling and closing system for vaccines
A high-performance filling line, like this one is currently being customized for delivery to Catalent. The filling line components are currently being assembled quickly and safely within Optima’s new CSPE Center. (Source: Optima)

Fast track delivery of a complete filling solution under isolator

Optima Group welcomes Catalent’s recent announcement that it has signed an agreement with a major global pharmaceutical company to accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing of a lead vaccine candidate for COVID-19 at Catalent’s facility in Bloomington, Indiana. Scale-up in production will include the use of an Optima high-speed vial filling line.

"Our employees are working rapidly to bring the completed vial line to Catalent’s biologics site in the United States. We are very pleased to be able to contribute to overcoming the coronavirus pandemic and to support Catalent in increasing its production capacities," says Gerhard Breu, Chairman of the Optima Pharma Division.
Further information on special machine solutions for the fight against COVID-19 is available at: www.optima-packaging.com/fightcovid-19

Filling and closing machine for vaccines
A wide variety of process steps are required for the filling of vaccines – from washing and sterilizing the vials to filling and closing. All system components are tested and accepted as part of the CSPE approach at Optima in Schwaebisch Hall. (Source: Optima)

Jan Deininger
+49 791 506-1472
OPTIMA packaging group GmbH - Alle Rechte vorbehalten.